Lundorff, MD L, Sjøgren, DmSci, MD P, Hansen, MD OB, Jonsson, MD T, Nielsen PR, Christrup, PhD, MSc(Pharm) L. Switching from high doses of pure µ-opioid agonists to transdermal buprenorphine in patients with cancer: A feasibility study. J of Opioid Management [Internet]. 2013 Jul. 1 [cited 2024 Nov. 24];9(4):255-62. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/568